NM_004380.3:c.2728A>G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_004380.3(CREBBP):c.2728A>G(p.Thr910Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00238 in 1,613,886 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004380.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREBBP | NM_004380.3 | c.2728A>G | p.Thr910Ala | missense_variant | Exon 14 of 31 | ENST00000262367.10 | NP_004371.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CREBBP | ENST00000262367.10 | c.2728A>G | p.Thr910Ala | missense_variant | Exon 14 of 31 | 1 | NM_004380.3 | ENSP00000262367.5 | ||
CREBBP | ENST00000382070.7 | c.2614A>G | p.Thr872Ala | missense_variant | Exon 13 of 30 | 1 | ENSP00000371502.3 | |||
CREBBP | ENST00000570939.2 | c.1333A>G | p.Thr445Ala | missense_variant | Exon 9 of 23 | 5 | ENSP00000461002.2 | |||
CREBBP | ENST00000573672.1 | n.-19A>G | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00232 AC: 353AN: 151926Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00240 AC: 603AN: 251324Hom.: 2 AF XY: 0.00226 AC XY: 307AN XY: 135840
GnomAD4 exome AF: 0.00239 AC: 3487AN: 1461844Hom.: 9 Cov.: 33 AF XY: 0.00239 AC XY: 1739AN XY: 727218
GnomAD4 genome AF: 0.00232 AC: 353AN: 152042Hom.: 0 Cov.: 31 AF XY: 0.00268 AC XY: 199AN XY: 74324
ClinVar
Submissions by phenotype
not provided Benign:6
- -
- -
CREBBP: BP4, BS1 -
This variant is associated with the following publications: (PMID: 20684013) -
- -
- -
not specified Benign:4
- -
- -
- -
- -
Tip-toe gait Pathogenic:1
Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. -
Rubinstein-Taybi syndrome due to CREBBP mutations Pathogenic:1
- -
CREBBP-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Rubinstein-Taybi syndrome Benign:1
- -
Intellectual disability Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at